ROM InWest works from a social mission: strengthening a sustainable economy and promoting a healthy living environment in North Holland. In this regard, we see innovative entrepreneurs as the flywheel of change - they apply and scale up innovation - thus creating social value. Their success determines our own impact. To give our shareholders and partners insight into our progress, we quantify our results. The figures and insights we show below will be built on in the coming period, in line with the information needs of our shareholders and the possibilities within our current capacity.
In 2022 and 2023, ROM InWest focused mainly on getting to know innovative entrepreneurs. We wanted to understand who they are, where their ambitions lie and which technologies make the biggest in North Holland to make social impact. At the same time, we laid a solid foundation with a new CRM and fund management system, linked to the national ROM NL data. This allows us to better follow entrepreneurs from their initial growth phase, become smarter and more effective as impact investors, and unlock knowledge that helps the entire region grow further.
Since 2021, our business developers spoke to 680 entrepreneurs.
211 introductory and progress interviews with entrepreneurs, spread across the transitions:
No Data Found
21 Entrepreneurs supported through intensive mentoring programme:
No Data Found
209 introductory and progress interviews with entrepreneurs, spread across the transitions: (Q1-Q3)
No Data Found
17 Entrepreneurs supported through intensive mentoring programme (Q1 to Q3):
No Data Found
No Data Found
No Data Found
No Data Found
No Data Found
€4.9 million invested in sustainable innovation.
We have invested in eight entrepreneurs so far.
In total, we have €12.3m of mobilised capital.
Number of transactions 2021 to Q1 2025.
No Data Found
No Data Found
No Data Found
No Data Found
€10.5 million invested in sustainable innovation.
We have invested in 11 entrepreneurs so far.
In total, we have €23.9m of mobilised capital.
Number of transactions 2021 to Q1 2025.
No Data Found
No Data Found
No Data Found
No Data Found
Methotrexate is currently the most commonly prescribed basic drug for rheumatoid arthritis worldwide. Sixty to eighty per cent of patients receive this drug. The problem, however, is that methotrexate is too...
Healthplus.ai is a Dutch MedTech scale-up from Amsterdam. Their AI system PERISCOPE® calculates each patient's risk of infection after surgery and gives the healthcare team clear actions to reduce that risk....
ThePhoneLab shows that sustainability and entrepreneurship can go hand in hand. 38% of consumers still choose to replace a phone in case of damage. ThePhoneLab provides life extension...
The energy market faces a major challenge: balancing supply and demand in an increasingly dynamic system. Traditional methods fall short of addressing the fluctuations of renewable energy sources, such as wind...